Literature DB >> 29858979

Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology.

Anna Medkova1, Josef Srovnal2,3, Jarmila Potomkova2,4, Jana Volejnikova2,3, Vladimir Mihal2,3.   

Abstract

BACKGROUND: Numerous articles related to S100 proteins have been recently published. This review aims to introduce this large protein family and its importance in the diagnostics of many pathological conditions in children and adults. DATA SOURCES: Based on original publications found in database systems, we summarize the current knowledge about the S100 protein group and highlight the most important proteins with focus on pediatric use.
RESULTS: The S100 family is composed of Ca2+ and Zn2+ binding proteins, which are present only in vertebrates. Some of these proteins can be used as diagnostic markers in cardiology (S100A1, S100A12), oncology (S100A2, S100A5, S100A6, S100A14, S100A16, S100P, S100B), neurology (S100B), rheumatology (S100A8/A9, S100A4, S100A6, and S100A12), nephrology and infections (S100A8, S100A9, S100A8/A9, S100A12). The most useful S100 proteins in pediatrics are S100A8, S100A9, heterodimers S100A8/A9, S100B and S100A12.
CONCLUSIONS: The S100 family members are promising biomarkers and provide numerous possibilities for implementation into clinical practice to optimize the differential diagnostic process.

Entities:  

Keywords:  Diagnostics; Marker; Pediatrics; S100

Mesh:

Substances:

Year:  2018        PMID: 29858979     DOI: 10.1007/s12519-018-0163-5

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  91 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage.

Authors:  D Gazzolo; M Bruschettini; M Lituania; G Serra; W Bonacci; F Michetti
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

3.  S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity.

Authors:  Zheng Yang; Wei Xing Yan; Hong Cai; Nicodemus Tedla; Chris Armishaw; Nick Di Girolamo; Hong Wei Wang; Taline Hampartzoumian; Jodie L Simpson; Peter G Gibson; John Hunt; Prue Hart; J Margaret Hughes; Michael A Perry; Paul F Alewood; Carolyn L Geczy
Journal:  J Allergy Clin Immunol       Date:  2006-10-06       Impact factor: 10.793

4.  Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin.

Authors:  M Steinbakk; C F Naess-Andresen; E Lingaas; I Dale; P Brandtzaeg; M K Fagerhol
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

5.  Calprotectin as a marker of inflammation in cystic fibrosis.

Authors:  B E Golden; P A Clohessy; G Russell; M K Fagerhol
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

6.  Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.

Authors:  Patrick Most; Hanna Seifert; Erhe Gao; Hajime Funakoshi; Mirko Völkers; Jörg Heierhorst; Andrew Remppis; Sven T Pleger; Brent R DeGeorge; Andrea D Eckhart; Arthur M Feldman; Walter J Koch
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

Review 7.  S100 proteins in cancer.

Authors:  Anne R Bresnick; David J Weber; Danna B Zimmer
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

Review 8.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

9.  Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns.

Authors:  Gianluca Terrin; Annalisa Passariello; Francesco Manguso; Gennaro Salvia; Luciano Rapacciuolo; Francesco Messina; Francesco Raimondi; Roberto Berni Canani
Journal:  Clin Dev Immunol       Date:  2011-05-30

10.  Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.

Authors:  Limin Zhang; Haowen Jiang; Gang Xu; Hui Wen; Bin Gu; Jun Liu; Shanghua Mao; Rong Na; Yan Jing; Qiang Ding; Yuanfang Zhang
Journal:  Mol Med Rep       Date:  2015-02-09       Impact factor: 2.952

View more
  1 in total

1.  [Role of TGF-β1/ILK/FSP1 signaling pathway in cyclosporin A-induced epithelialmesenchymal transition in cultured renal tubular epithelial cells].

Authors:  Zhixun Bai; Jing Lu; Yibin Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.